MyoPS: A Benchmark of Myocardial Pathology Segmentation Combining Three-Sequence Cardiac Magnetic Resonance Images
Authors:
Lei Li,
Fu** Wu,
Sihan Wang,
Xinzhe Luo,
Carlos Martin-Isla,
Shuwei Zhai,
Jianpeng Zhang,
Yanfei Liu7,
Zhen Zhang,
Markus J. Ankenbrand,
Haochuan Jiang,
Xiaoran Zhang,
Linhong Wang,
Tewodros Weldebirhan Arega,
Elif Altunok,
Zhou Zhao,
Feiyan Li,
Jun Ma,
** Yang,
Elodie Puybareau,
Ilkay Oksuz,
Stephanie Bricq,
Weisheng Li,
Kumaradevan Punithakumar,
Sotirios A. Tsaftaris
, et al. (7 additional authors not shown)
Abstract:
Assessment of myocardial viability is essential in diagnosis and treatment management of patients suffering from myocardial infarction, and classification of pathology on myocardium is the key to this assessment. This work defines a new task of medical image analysis, i.e., to perform myocardial pathology segmentation (MyoPS) combining three-sequence cardiac magnetic resonance (CMR) images, which…
▽ More
Assessment of myocardial viability is essential in diagnosis and treatment management of patients suffering from myocardial infarction, and classification of pathology on myocardium is the key to this assessment. This work defines a new task of medical image analysis, i.e., to perform myocardial pathology segmentation (MyoPS) combining three-sequence cardiac magnetic resonance (CMR) images, which was first proposed in the MyoPS challenge, in conjunction with MICCAI 2020. The challenge provided 45 paired and pre-aligned CMR images, allowing algorithms to combine the complementary information from the three CMR sequences for pathology segmentation. In this article, we provide details of the challenge, survey the works from fifteen participants and interpret their methods according to five aspects, i.e., preprocessing, data augmentation, learning strategy, model architecture and post-processing. In addition, we analyze the results with respect to different factors, in order to examine the key obstacles and explore potential of solutions, as well as to provide a benchmark for future research. We conclude that while promising results have been reported, the research is still in the early stage, and more in-depth exploration is needed before a successful application to the clinics. Note that MyoPS data and evaluation tool continue to be publicly available upon registration via its homepage (www.sdspeople.fudan.edu.cn/zhuangxiahai/0/myops20/).
△ Less
Submitted 10 January, 2022;
originally announced January 2022.
